Literature DB >> 20599589

Xenin delays gastric emptying rate and activates the brainstem in mice.

Eun Ran Kim1, Tooru M Mizuno.   

Abstract

Xenin, a 25-amino acid gastrointestinal peptide, inhibits feeding by acting through the central nervous system. Gastrointestinal hormones reduce food intake partly by activating the brainstem and inhibiting gastric emptying. Therefore, we hypothesized that xenin delays gastric emptying through the activation of the brainstem cells. To address this hypothesis, we examined the effect of intraperitoneal (i.p.) injection of xenin on gastric emptying rate and brainstem Fos expression in mice. Gastric emptying rate was reduced by about 93% in xenin-treated mice compared to saline-treated control mice. The i.p. xenin injection significantly increased Fos-immunoreactive cells in the nucleus of the solitary tract (NTS) of the brainstem, but not area postrema (AP) and dorsal motor nucleus of the vagus (DMV). These findings support the hypothesis that xenin-induced anorexia is at least partly due to delayed gastric emptying and the activation of the NTS cells. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599589     DOI: 10.1016/j.neulet.2010.06.055

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.

Authors:  Sara Chowdhury; Dominic N Reeds; Dan L Crimmins; Bruce W Patterson; Erin Laciny; Songyan Wang; Hung D Tran; Terry A Griest; David A Rometo; Judit Dunai; Michael J Wallendorf; Jack H Ladenson; Kenneth S Polonsky; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-19       Impact factor: 4.052

2.  Metabolic responses to xenin-25 are altered in humans with Roux-en-Y gastric bypass surgery.

Authors:  Karin Sterl; Songyan Wang; Lauren Oestricker; Michael J Wallendorf; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  Peptides       Date:  2016-06-07       Impact factor: 3.750

3.  Xenin-25 increases cytosolic free calcium levels and acetylcholine release from a subset of myenteric neurons.

Authors:  Sheng Zhang; Krzysztof Hyrc; Songyan Wang; Burton M Wice
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-10-18       Impact factor: 4.052

4.  Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans.

Authors:  Sheng Zhang; Songyan Wang; Matthew D Puhl; Xuntian Jiang; Krzysztof L Hyrc; Erin Laciny; Michael J Wallendorf; Kirk L Pappan; Joseph T Coyle; Burton M Wice
Journal:  Diabetes       Date:  2014-11-03       Impact factor: 9.461

5.  Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.

Authors:  Songyan Wang; Lauren Z Oestricker; Michael J Wallendorf; Karin Sterl; Judit Dunai; C Rachel Kilpatrick; Bruce W Patterson; Dominic N Reeds; Burton M Wice
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

6.  Xenin is a novel anorexigen in goldfish (Carassius auratus).

Authors:  Brent Kerbel; Kimberly Badal; Lakshminarasimhan Sundarrajan; Ayelen Blanco; Suraj Unniappan
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

7.  Neurotensin and Xenin Show Positive Correlations With Perceived Stress, Anxiety, Depressiveness and Eating Disorder Symptoms in Female Obese Patients.

Authors:  Ellen Wölk; Andreas Stengel; Selina Johanna Schaper; Matthias Rose; Tobias Hofmann
Journal:  Front Behav Neurosci       Date:  2021-02-16       Impact factor: 3.558

8.  Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin.

Authors:  Christine M Martin; Vadivel Parthsarathy; Annie Hasib; Ming T Ng; Stephen McClean; Peter R Flatt; Victor A Gault; Nigel Irwin
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.